Study Stopped
Device is no longer investigational. It has been approved by the FDA as an HUD under HDE H190005.
Vertebral Body Tethering Treatment for Idiopathic Scoliosis
Safety and Feasibility of a Vertebral Body Tethering Technique for Pediatric Idiopathic Scoliosis
1 other identifier
interventional
2
1 country
1
Brief Summary
This study will determine whether vertebral body tethering is a safe and feasible method of treatment for pediatric idiopathic scoliosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2019
CompletedFirst Posted
Study publicly available on registry
January 14, 2019
CompletedStudy Start
First participant enrolled
June 24, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2019
CompletedApril 12, 2023
April 1, 2023
6 months
January 10, 2019
April 10, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Safety: Incidence of Treatment-Emergent Adverse Events
Intraoperative and post-intervention medical events or signs and symptoms of complications arising after the start of study intervention will be captured. The event description, date of onset, end date, severity, and outcome will be documented. The frequencies, type, body system, severity, and relationship to the study intervention will also be summarized. A distinction will be made between those events which are "device-related" and "non device-related".
2 years after last subject's device implantation
Secondary Outcomes (2)
Feasibility: Incidence of Successfully Implanted Tether Devices
2 years after last subject's device implantation
Efficacy: Comparison of Preoperative and Postoperative Cobb Angle
2 years after last subject's device implantation
Study Arms (1)
Anterior Vertebral Body Tethering
EXPERIMENTALSubjects who will be undergoing the anterior vertebral body tethering surgery.
Interventions
Vertebral body tethering through anterior thoracoscopic approach under general anesthesia and fluoroscopic guidance.
Eligibility Criteria
You may qualify if:
- Males or females age 8 to 16 years old at time of enrollment (inclusive)
- Diagnosis of idiopathic scoliosis
- Sanders bone age of less than or equal to 4
- Thoracic or thoracolumbar/lumbar curves of greater than or equal to 35 degrees and less than or equal to 60 degrees from levels T4 through L3
- Lenke classification of 1, 2, 3, 5, or 6
- Patient has already been identified for and recommended to have surgical intervention
- Spina bifida occulta is permitted
- Spondylolysis or Spondylolisthesis is permitted, as long as it is non-operative, the patient has not had any previous surgery for this, and no surgery is planned in the future
- Completed standard-of-care procedures as outlined in Section 5
You may not qualify if:
- Pregnancy (current)
- Prior spinal or chest surgery
- MRI abnormalities (including syrinx greater than 4mm, Chiari malformation, or tethered cord)
- Neuromuscular, thoracogenic, cardiogenic scoliosis, or any other non-idiopathic scoliosis
- Associated syndrome, including Marfan Disease or Neurofibromatosis
- Sanders bone age greater than 4
- Thoracic or thoracolumbar/lumbar curves less than 35 degrees or greater than 60 degrees
- Compensatory curve greater than 35 degrees without intent to treat surgically
- Unable or unwilling to firmly commit to returning for required follow-up visits
- Investigator judgement that the subject/family may not be a candidate for the intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ochsner Health System- Jefferson Hwy
New Orleans, Louisiana, 70121, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Lawrence Haber, MD
Ochsner Health System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2019
First Posted
January 14, 2019
Study Start
June 24, 2019
Primary Completion
December 12, 2019
Study Completion
December 12, 2019
Last Updated
April 12, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share